Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Coley Pharmaceutical Group, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Coley Pharmaceutical Group, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Coley Pharmaceutical Group, Inc. since 2005.
The reporting company's ticker symbol is COLY. The reporting company's CIK number is 1319197.
The total value of stock buying since 2005 is $1,631,679.
The total value of stock sales since 2005 is $319,491.
The total value of stock option exercises since 2005 is $24,149.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2007-12-06||Karobath Manfred E (Director)||Sale||27,000||7.93||214,110|
|2007-08-29||Krieg Arthur M (SVP, R & D, Chief Scien. Off.)||Sale||21,070||1.89||39,822|
|2007-05-11||Thomas James E (Director)||Buy||60,000||8.66||519,600|
|2007-05-10||Thomas James E (Director)||Buy||100,000||8.68||868,000|
|2007-05-08||Karobath Manfred E (Director)||Buy||27,000||9.04||244,079|
|2006-12-07||Krieg Arthur M (SVP, R & D, Chief Scien. Off.)||Sale||18,122||2.24||40,593|
|2006-10-13||Krieg Arthur M (SVP, R & D, Chief Scien. Off.)||Sale||13,210||1.89||24,966|
|2005-11-29||Krieg Arthur M (SVP, R & D, Chief Scien. Off.)||Option Ex||21,000||1.15||24,149|
Insider trading activities including stock purchases, stock sales, and option exercises of COLY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Coley Pharmaceutical Group, Inc. (symbol COLY, CIK number 1319197) see the Securities and Exchange Commission (SEC) website.